A comparative analysis of biosimilar vs. originator filgrastim in combination with plerixafor for stem cell mobilization in lymphoma and multiple myeloma: a propensity-score weighted multicenter approach.

Am J Hematol 2017 Sep 24;92(9):E557-E559. Epub 2017 Jul 24.

Institute of Hematology "Seràgnoli" University Hospital S. Orsola-Malpighi, Bologna, Italy.

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24817DOI Listing
September 2017
47 Reads

Publication Analysis

Top Keywords

lymphoma multiple
4
mobilization lymphoma
4
cell mobilization
4
plerixafor stem
4
multiple myeloma
4
myeloma propensity-score
4
multicenter approach
4
weighted multicenter
4
propensity-score weighted
4
combination plerixafor
4
stem cell
4
analysis biosimilar
4
originator filgrastim
4
filgrastim combination
4
comparative analysis
4
biosimilar originator
4
propensity-score
1
originator
1
multicenter
1
approach
1

Similar Publications